Alkermes (ALKS) Non Operating Investment Income (2014)

Alkermes (ALKS) reported Non Operating Investment Income of $29.6 million for Q4 2014, up 82155.56% quarter-over-quarter from $36000.0 in Q3 2014.

Alkermes (ALKS) Non Operating Investment Income (2014) Analysis & Trends

Alkermes (ALKS) has 1 years of Non Operating Investment Income data on file, last reported at $29.6 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Op. Investment Inc. (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	-

Download Data